Acorda Therapeutics, Inc. Restricted Cash
Acorda Therapeutics, Inc. had Restricted Cash of $700.00 thousand as of 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Balance Sheet › Assets › Restricted Cash and Cash Equivalent
us-gaap:RestrictedCash · last filed 2024-04-01
- 2023-12-31: Restricted Cash $700.00K.
- 2022-06-30: Restricted Cash $12.40M.
- 2022-03-31: Restricted Cash $18.60M.
| Period end | Restricted Cash |
|---|---|
| 2023-12-31 | $700.00K 10-K · filed 2024-04-01 |
| 2022-06-30 | $12.40M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $18.60M 10-Q · filed 2022-05-13 |